KDM2B and neoplasm: In conclusion, we now report that KDM2B is preferentially expressed therapeutically resistant pool of GSCs, creating a dependency for which inhibition leads to accumulation of DNA damage, which if left unrepaired induces apoptosis and significantly reduces the pool of stem‐like tumor cells.